Role of the breast cancer resistance protein (ABCG2) in drug transport.
about
ABC transporters in fish species: a reviewA long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malariaTransporters at CNS barrier sites: obstacles or opportunities for drug delivery?Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.Blood brain barrier: a challenge for effectual therapy of brain tumorsPharmacogenetic study of deferasirox, an iron chelating agentIn silico prediction of inhibition of promiscuous breast cancer resistance protein (BCRP/ABCG2)Epigenetic mechanisms involved in differential MDR1 mRNA expression between gastric and colon cancer cell lines and rationales for clinical chemotherapyN-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918) as a chemical ATP-binding cassette transporter family G member 2 (Abcg2) knockout model to study nitrofurantoin tIdentification and functional characterization of breast cancer resistance protein in human bronchial epithelial cells (Calu-3).Regulation of gene expression in brain tissues of rats repeatedly treated by the highly abused opioid agonist, oxycodone: microarray profiling and gene mapping analysis.Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transport.Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapiesHepatocellular exposure of troglitazone metabolites in rat sandwich-cultured hepatocytes lacking Bcrp and Mrp2: interplay between formation and excretion.MDM2 antagonist nutlin-3a reverses mitoxantrone resistance by inhibiting breast cancer resistance protein mediated drug transportRole of basic residues within or near the predicted transmembrane helix 2 of the human breast cancer resistance protein in drug transport.Role of placental ATP-binding cassette (ABC) transporters in antiretroviral therapy during pregnancy.Fluorescence resonance energy transfer (FRET) analysis demonstrates dimer/oligomer formation of the human breast cancer resistance protein (BCRP/ABCG2) in intact cells.Identification of proline residues in or near the transmembrane helices of the human breast cancer resistance protein (BCRP/ABCG2) that are important for transport activity and substrate specificity.Vascular Recruitment of Human Retinoblastoma Cells by Multi-Cellular Adhesive Interactions with Circulating Leukocytes.Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1.Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).The contribution of the ABCG2 C421A polymorphism to cancer susceptibility: a meta-analysis of the current literature.Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters.Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug ResistanceATP-binding cassette efflux transporters in human placenta.Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update.Modification of topoisomerases in mammospheres derived from breast cancer cell line: clinical implications for combined treatments with tyrosine kinase inhibitors.Membrane topology of the human breast cancer resistance protein (BCRP/ABCG2) determined by epitope insertion and immunofluorescence.Cancer stem cells and side population cells in breast cancer and metastasis.ABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors.Hormonal regulation of BCRP expression in human placental BeWo cellsHydrogen-bond formation of the residue in H-loop of the nucleotide binding domain 2 with the ATP in this site and/or other residues of multidrug resistance protein MRP1 plays a crucial role during ATP-dependent solute transportHistological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma.The nuclear epidermal growth factor receptor signaling network and its role in cancer.A physiologically based pharmacokinetic model of mitoxantrone in mice and scale-up to humans: a semi-mechanistic model incorporating DNA and protein binding.Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS.The emerging pharmacotherapeutic significance of the breast cancer resistance protein (ABCG2).BCRP Inhibition: from Data Collection to Ligand-Based Modeling.Localization of breast cancer resistance protein (Bcrp) in endocrine organs and inhibition of its transport activity by steroid hormones.
P2860
Q26823286-D5466E20-89C4-44B6-8D60-AB030BF8F14CQ27644391-F94BA139-9921-423E-9C62-C3AE5A279991Q27690256-311C105C-9972-44FD-8AFF-541A493C8CC2Q27851688-8E79F647-FD8E-4493-A3F1-7A6B6B0915E4Q28081947-72526D01-1698-4A11-925F-ED44BCA70BBCQ28533457-6AC1003C-1B1D-4D03-AEB6-7BE31AD13ED9Q28540667-6FC82065-1443-4AE5-BD20-C3D51C0D3E4CQ33357010-651E668F-CD8C-49CC-B35F-8FC944975FBEQ33370268-2558C989-245C-42D0-A9C4-B54F7112C951Q33506860-769F1F08-7378-4DE5-AA10-E56731982B3EQ33574623-099A0311-C4E8-4A4A-B093-1AEBA516627AQ33672739-4996F995-FEB1-4C3B-8D68-2D6AFBB5F9B2Q33730375-B7826FA3-6731-406C-86AB-9BA6F763AD94Q33742713-B3D6588C-DA76-462A-BD6D-5FE762FA969AQ33860877-A5E5990F-956A-4A8C-85B0-1402DA9493B3Q33890952-47406680-0720-4B4D-923A-C5E058972B7FQ33954823-D0E97C22-690F-4249-821F-DEB6E7F9814BQ33980380-35872F3A-BCE7-414D-813C-2EFC146810BFQ33997565-3CCD21B9-FEFE-43E7-9320-2631793E8A91Q34015100-19C23286-8B21-486C-8ED7-4987F404CE3AQ34046157-7B39CAD5-DBC3-43C6-A3E2-42CBED59FF9AQ34176588-6874232C-95FA-456B-8A6B-FD3C515C805DQ34399824-1530BBE5-EE4B-4A05-BE15-ACE18BDD2104Q34568808-9B73212C-0288-4E90-A958-D0367B533CAAQ34774854-54512B16-F639-44FB-A140-87DA53B57051Q34843023-F7A32793-1646-4E6A-A40F-C7AE24E05842Q34871636-98D9C1DB-8F2F-4953-B771-FD67E7BE0803Q34896154-9A4244CB-446F-4135-B777-C95E7C8E37D5Q34897883-72189DB3-FDE8-485F-8E3D-A6CBD439BAA6Q35038054-28A42776-028A-4BA9-83E1-B19019C47D11Q35171274-A973635D-CB27-47CA-80CD-4BE786230D50Q35608456-F98D07C2-F328-4E60-8F47-F247CE20FF4BQ35742010-81617E6A-AAD5-45CE-9CA3-D380F4132F3DQ35757248-13AD4656-0E1E-45C5-AB33-FF27FFF1D99AQ35834849-AA0F264D-0FD7-4B5B-B553-C35BA15400D7Q35888381-91DF975B-1426-4BD7-8C2B-1F62658E337DQ36007494-FFF8185A-1741-4E00-A8E0-251AE48C9D4EQ36052743-F939FE6A-22D3-4E6B-9F69-8A3EC190ED9DQ36093462-DC18D848-E7AA-47D9-ACC6-528958759A39Q36150190-072A2E14-05F2-470C-A873-9E0810E13F43
P2860
Role of the breast cancer resistance protein (ABCG2) in drug transport.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Role of the breast cancer resistance protein (ABCG2) in drug transport.
@ast
Role of the breast cancer resistance protein (ABCG2) in drug transport.
@en
type
label
Role of the breast cancer resistance protein (ABCG2) in drug transport.
@ast
Role of the breast cancer resistance protein (ABCG2) in drug transport.
@en
prefLabel
Role of the breast cancer resistance protein (ABCG2) in drug transport.
@ast
Role of the breast cancer resistance protein (ABCG2) in drug transport.
@en
P2860
P356
P1433
P1476
Role of the breast cancer resistance protein (ABCG2) in drug transport.
@en
P2093
Jashvant D Unadkat
Qingcheng Mao
P2860
P2888
P304
P356
10.1208/AAPSJ070112
P407
P577
2005-05-11T00:00:00Z
P5875
P6179
1032127936